Private Equity Value Creation: 2026 Levers Guide
HomePrivate Equity Value Creation in 2026: How PE Firms Actually Grow the Businesses They Buy

Private Equity Value Creation in 2026: The 3 Levers & The 100-Day Plan

Quick Answer

Christoph Totter

Christoph Totter · Managing Partner, CT Acquisitions

Buy-side M&A across 76+ active capital partners · PE strategy & portfolio company value creation reference · Updated June 6, 2026

Private equity creates value through three levers: (1) EBITDA growth, increasing the company’s earnings via revenue growth (new products, markets, sales force, pricing), margin improvement (operational efficiency, procurement, technology), and add-on acquisitions (‘buy-and-build’); (2) multiple expansion, selling the company at a higher EBITDA multiple than it was bought for, achieved by making it bigger, more diversified, more professionally managed, faster-growing, and less risky; and (3) deleveraging, using the company’s cash flow to pay down the acquisition debt, which increases the equity portion of the value over the hold period (typically 3-7 years). The modern emphasis has shifted from financial engineering toward operational value creation, executed through a structured 100-day plan and a dedicated operating-partner team. For an owner, this is why a PE-backed buyer can often pay a competitive price: they’re underwriting the value they intend to add, not just the business as it stands today.

Looking to acquire in this space?

CT Acquisitions sources proprietary, off-market deals for serious buyers. Tell us your mandate and we will bring you businesses that fit. No cost to explore.

Book a Call With Our Team
Share Your Buy Box

A corporate boardroom at golden hour

Private equity makes money in three ways: growing the company’s earnings, selling it at a higher multiple than they paid, and paying down debt with its cash flow. In the 1980s the story was mostly leverage and cost-cutting. Today the returns come increasingly from operational value creation, actually making the business bigger, better-run, faster-growing, and more diversified, executed through a structured plan and a team of operating partners. Understanding the playbook matters whether you’re an investor, an operator, or an owner deciding whether to sell to a PE-backed buyer, because it explains how they think about your business and why they’ll pay what they pay.

We’re CT Acquisitions, a buy-side M&A advisory firm, we work with PE firms and their portfolio companies on acquisitions, and with owners considering a sale to one. For owners: a PE-backed buyer underwriting a value-creation plan can often justify a competitive price, and a sell-side process is how you make them compete for it, with the buyer-paid model, you pay no advisory fee. See our broker alternative guide, our how to sell your business guide, and a free valuation to set your number.

What this guide covers

  • Lever 1, EBITDA growth: grow revenue (new products/markets/sales capacity/pricing), expand margins (efficiency, procurement, technology), and acquire add-ons (‘buy-and-build’)
  • Lever 2, multiple expansion: exit at a higher EBITDA multiple than entry, by making the company bigger, more diversified, better-managed, faster-growing, and less risky
  • Lever 3, deleveraging: use the company’s cash flow to pay down acquisition debt over the hold (typically 3-7 years), increasing the equity value
  • The modern shift: from financial engineering toward operational value creation, executed via a 100-day plan and dedicated operating partners
  • Buy-and-build / platform-and-add-on: a ‘platform’ company acquires smaller ‘add-ons’ at lower multiples, creating instant value through multiple arbitrage and scale
  • For owners: a PE buyer prices the value they plan to add, not just today’s business, which is why a competitive process matters; get your number with our free tool

The three levers of private equity value creation

CT Acquisitions · 2026 PE Strategy Signal

What Founders Need to Know About PE Value Creation

Across our conversations with founder-sellers and PE portfolio companies in 2026:

  • The 100-day plan is not optional. PE firms execute aggressive KPI dashboards, management alignment, and quick-win operational fixes — founders staying past close should expect this rhythm.
  • Buy-and-build accelerates EBITDA growth, not just revenue. Bolt-on synergies (procurement, shared services, technology) typically add 10-25% to bolt-on EBITDA over 18 months post-integration.
  • Multiple expansion requires real category leadership, not just scale. Buyers re-rate from 7x to 12x EBITDA only when the platform proves it can be sold as a #1-or-#2 category player.

Multiple at a Glance · 2026

PE Value Creation Levers · 2026

Relative contribution by lever across typical LBO hold period.

EBITDA growth (revenue + margin + M&A)~50% of MOIC
Multiple expansion (re-rating)~30% of MOIC
Debt paydown (financial)~20% of MOIC

Source: CT Acquisitions analysis of PE portfolio company value creation. MOIC (multiple on invested capital) decomposition varies by industry, strategy, and hold period.

Related Cluster GuideFor the foundational reference on types of private equity in 2026 (LBO, growth equity, venture, mezzanine), see our companion guide.

Every dollar of return a PE firm earns on a deal traces to one of three sources. A simplified illustration:

Lever What it means How PE drives it
1. EBITDA growth Increase the company’s earnings during the hold Revenue growth (new products, new markets/geographies, more sales capacity, better pricing, cross-selling), margin improvement (operational efficiency, procurement leverage, technology/automation, organizational redesign), and add-on acquisitions that bolt on more earnings
2. Multiple expansion Sell the company at a higher EBITDA multiple than it was bought at Make it bigger (larger companies command higher multiples), more diversified (less customer/product/geographic concentration), more professionally managed (real systems, reporting, leadership depth), faster-growing, and lower-risk, all of which a future buyer will pay more for per dollar of EBITDA
3. Deleveraging Pay down the debt used to buy the company, using the company’s own cash flow The acquisition is funded partly with debt; the company’s free cash flow services and amortizes it over the hold, so even with no change in enterprise value, the equity slice grows as debt shrinks

How we see this play out: across the PE-backed buyers in our network of 100+ active capital partners, the firms paying the most competitive prices for founder-owned businesses are almost always the ones with a concrete value-creation thesis, a specific path to grow EBITDA and reduce risk, not just a financing structure. They’re buying the future they intend to build.

Lever 1 in detail: how PE grows EBITDA

Revenue growth (‘top-line value creation’)

Margin improvement (‘operational value creation’)

Add-on acquisitions (‘buy-and-build’ / ‘platform-and-add-on’)

One of the most powerful and most common strategies: acquire a platform company in a fragmented industry, then bolt on smaller add-on acquisitions. The math is compelling, add-ons are typically bought at lower multiples than the platform (a small company sells for, say, 5x; inside a larger platform that EBITDA is implicitly valued at the platform’s 9x), creating instant ‘multiple arbitrage’ value, plus revenue synergies (cross-sell), cost synergies (shared services), and a bigger combined entity that exits at a higher multiple still. Many of the PE-backed buyers active in home services, healthcare services, business services, distribution, and specialty manufacturing are running exactly this play, which is why founder-owned businesses in those sectors get steady inbound interest.

Lever 2 in detail: how the multiple expands

A future buyer pays more per dollar of EBITDA for a company that is:

A founder-owned business often scores low on several of these (concentration, owner dependency, informal reporting), which is precisely the gap a PE firm intends to close, and the reason they can buy at one multiple and sell at a higher one.

Lever 3 in detail: deleveraging

A PE acquisition is typically funded with a mix of equity (the fund’s money) and debt (from lenders). Over the hold, the company’s free cash flow pays interest and amortizes principal. Even if enterprise value were flat, the equity value, enterprise value minus net debt, rises as net debt falls. In practice deleveraging works alongside EBITDA growth and multiple expansion; it’s the quietest of the three levers but a real contributor, and it’s why cash-generative businesses with predictable free cash flow are attractive PE targets.

The 100-day plan and the operating model

Modern PE firms don’t wait to figure out the value-creation plan after closing, they build it during diligence and execute from day one. The 100-day plan typically covers: securing quick wins (pricing, procurement, obvious efficiencies), upgrading financial reporting and KPIs, assessing and strengthening the leadership team, building the add-on acquisition pipeline, and setting the strategic priorities for the hold. Many firms run a dedicated operating-partner or portfolio-operations team, former operators who work hands-on with portfolio companies, and bring playbooks, vendor relationships, and talent networks. This operational muscle is the main reason ‘value creation’ has become the dominant phrase in PE: returns increasingly have to be earned through operating improvement, not manufactured through leverage.

How we know this: the ranges, timelines, and dynamics on this page come from the transactions we’ve worked on and the buyer mandates in our network of 100+ active capital partners. They’re informed starting points, not guarantees, your actual outcome depends on the specifics of your business and your situation.

What this means if you’re an owner considering a PE sale

Before You Talk to PE

Know your number before a PE buyer names theirs

PE buyers price the future they intend to build, don’t walk in without your own grounded number. Our free 90-second tool gives you a sector-adjusted valuation range based on current 2026 transactions, no email gate, no obligation.

Get a Free Valuation →

Want more deal flow in this sector?

We run targeted, confidential outreach to owners and bring acquirers proprietary deals that never hit the open market. Tell us what you are looking for.

Get Proprietary Deal Flow
Share Your Buy Box

The five pillars of how CT Acquisitions works

$0 to Sellers

Buyer pays our fee. Founders never write a check.

No Retainer

No engagement letter. No upfront cost. No exclusivity contract.

100+ Capital Partners

Search funders, family offices, lower-middle-market PE, strategics.

Sequential, Not Auction

Confidential introductions to the right buyers. No bidding war.

60-120 Day Close

Not 9-12 months. Not 18 months. Months, not years.

No Pitch · No Pressure

Considering a sale to a PE-backed buyer?

We work with PE firms and their platforms, and with owners on the other side of the table. We’ll tell you which buyer types fit your business, what they’d likely pay, and how to make them compete. No engagement letter, no retainer, no obligation.

Start a Confidential Conversation →

Christoph Totter, Founder of CT Acquisitions

About the Author

Christoph Totter is the founder of CT Acquisitions, a buy-side partner headquartered in Sheridan, Wyoming. We work directly with 100+ buyers, search funders, family offices, lower middle-market PE, and strategic consolidators, including direct mandates with the largest consolidators that other intermediaries cannot access. The buyers pay us when a deal closes, not the seller. No retainer, no exclusivity, no contract until close. Connect on LinkedIn · Get in touch

Private Equity Value Creation: Frequently Asked Questions

How does private equity create value?

Through three levers: (1) EBITDA growth, increasing the company’s earnings via revenue growth (new products, markets, sales capacity, pricing, cross-sell), margin improvement (operational efficiency, procurement, technology, organizational redesign), and add-on acquisitions; (2) multiple expansion, exiting at a higher EBITDA multiple than the entry multiple, achieved by making the company bigger, more diversified, more professionally managed, faster-growing, and lower-risk; and (3) deleveraging, using the company’s cash flow to pay down the acquisition debt over the hold period, which grows the equity portion of the value. Modern PE emphasizes operational value creation, executed via a 100-day plan and dedicated operating partners, over the financial engineering that dominated earlier eras.

What is the 100-day plan in private equity?

It’s the structured action plan a PE firm executes immediately after acquiring a company, built during due diligence, not after closing. It typically covers securing quick wins (pricing, procurement, obvious efficiencies), upgrading financial reporting and KPIs, assessing and strengthening the leadership team, building the add-on acquisition pipeline, and setting strategic priorities for the hold period. The point is to start creating value from day one rather than spending the first year orienting; many firms support it with an operating-partner or portfolio-operations team that works hands-on with the company.

What is buy-and-build in private equity?

Buy-and-build (also called platform-and-add-on or roll-up) is a strategy where a PE firm acquires a ‘platform’ company in a fragmented industry, then bolts on smaller ‘add-on’ acquisitions. It creates value several ways: add-ons are typically bought at lower multiples than the platform (so that EBITDA is instantly worth more inside the larger entity, ‘multiple arbitrage’), the combined company captures revenue synergies (cross-sell) and cost synergies (shared services), and the bigger combined business commands a higher exit multiple. It’s a dominant play in home services, healthcare services, business services, distribution, and specialty manufacturing, which is why founder-owned businesses in those sectors see steady PE interest.

What is multiple expansion?

Multiple expansion (or multiple arbitrage) is selling a company at a higher EBITDA multiple than it was purchased at, capturing value purely from the higher valuation, separate from any growth in earnings. PE firms engineer it by making the company bigger (scale commands a premium), more diversified (lower concentration risk), more professionally managed (audited financials, real KPIs, leadership depth), faster-growing, and lower-risk overall, all things a future buyer will pay more per dollar of EBITDA for. A founder-owned business often scores low on these dimensions at entry, which is exactly the gap a PE buyer plans to close.

Why does private equity buy founder-owned businesses?

Because founder-owned businesses frequently have untapped value PE knows how to unlock: pricing power that’s never been exercised, customer concentration that can be diversified, informal systems that can be professionalized, no add-on acquisitions yet in a fragmented sector, and an owner whose dependency can be replaced with a real management team. PE buyers underwrite the EBITDA growth, multiple expansion, and deleveraging they expect to achieve, which is why a PE-backed buyer with a credible value-creation thesis can often justify a competitive price for a business that, on its trailing numbers alone, might look fully valued.

How long does private equity hold a company?

Typically 3-7 years, often around 4-6, though it varies with the strategy, the cycle, and the fund’s life. Some buy-and-build platforms are held longer to complete the acquisition program; some quick-turnaround situations exit faster; ‘continuation funds’ can extend a hold beyond the original fund. Over that period the firm executes the value-creation plan, EBITDA growth, multiple expansion, deleveraging, then exits via a sale to a strategic acquirer, a sale to a larger PE fund, a recapitalization, or (less commonly for lower-middle-market companies) a public offering.

Is private equity value creation just cost-cutting?

Not anymore, and not for most modern firms. The ‘cost-cutting’ caricature dates from an era when leverage and expense reduction drove most returns. Today, returns increasingly have to be earned through operational improvement: revenue growth, commercial excellence, new products, geographic expansion, add-on acquisitions, technology, and yes, efficiency, but as one tool among many, not the whole plan. Right-sizing an organization is sometimes part of the playbook, but a firm whose entire thesis is cutting costs is unusual and generally not the one that pays the best prices for growing businesses.

How can I get the best price selling my business to private equity?

Three things: know your number first (a defensible, sector-adjusted valuation, so you’re not negotiating blind); understand the buyer’s value-creation thesis (the right PE-backed buyer is one whose plan genuinely fits your business and sector, and a fit-matched buyer pays more and runs the process better); and create competition (one PE buyer’s first offer is rarely their best, a sell-side process that puts several credible PE and strategic buyers in the room turns ‘a fair price’ into ‘the best price’). With the buyer-paid model, you don’t pay an advisory fee for that process, the buyer does at closing.

Related research






Vertical M&A guides, sell your business by industry

Sector-specific guides with real multiples, the buyers, and the process:

Agency & tech

Logistics

Facility services

Digital infrastructure

Vertical M&A guides, sell your business by industry

Sector-specific guides with real multiples, the buyers acquiring, and the process:

Fire / life safety / security / AV / low-voltage

Healthcare services

Technology services

In-depth M&A guides, fire sprinkler & elevator service

Deep-dive guides on multiples, the named PE platforms acquiring, the recurring-revenue math, and how to prepare a sale. Sellers pay nothing; the buyer pays the fee at closing.

In-depth M&A guides, co-packing & industrial distribution

Deep-dive guides on multiples, the named PE platforms acquiring, and how to prepare a sale. Sellers pay nothing; the buyer pays the fee at closing.

In-depth M&A guides, medical billing & RCM

Deep-dive guide on multiples, named PE platforms (R1 RCM, Waystar, Ensemble, GeBBS), the KPI playbook, and how to prepare. Sellers pay nothing; the buyer pays the fee at closing.

In-depth M&A guide, RIA / wealth management firms

Deep-dive guide on 2026 multiples (median 11.6x EBITDA, premium 16x+), named aggregators (Wealth Enhancement, Mercer, Mariner), and the premium playbook. Sellers pay nothing; the buyer pays the fee at closing.

In-depth M&A guide, physical therapy practices

Deep-dive guide on 2026 multiples (3x-16x EBITDA), named PE consolidators (Upstream, Athletico, Confluent, Ivy, ATI), the productivity playbook, and how to prepare. Sellers pay nothing; the buyer pays the fee at closing.

In-depth M&A guide, urgent care centers

Deep-dive guide on 2026 multiples (3x-15x+ EBITDA), named PE-backed platforms (CityMD, GoHealth, FastMed, AFC), hospital-system buyers (Ardent, Bon Secours, HCA), and the operator KPI playbook. Sellers pay nothing; the buyer pays the fee at closing.

In-depth M&A guide, clinical laboratories

Deep-dive guide on 2026 multiples (4x-14x EBITDA), named national buyers (Quest, Labcorp, Sonic, NeoGenomics), PE-backed platforms (Aculabs/Ampersand), and the operator KPI playbook including PAMA / EKRA / CLIA / CAP. Sellers pay nothing; the buyer pays the fee at closing.

In-depth M&A guide, bookkeeping businesses

Deep-dive guide on 2026 multiples (1.5x-8x), the named buyer pool (Pilot, FinancePal, Acuity, BooXkeeping, plus PE-backed CPA platforms like Citrin Cooperman/Eisner/Aprio), the post-Bench market reset, and the recurring-revenue playbook. Sellers pay nothing; the buyer pays the fee at closing.

In-depth M&A guide, infusion therapy businesses

Deep-dive guide on 2026 multiples (5x-14x EBITDA), named public buyers (Option Care, Optum, BrightSpring) and PE-backed platforms (KabaFusion, Soleo, CSI). Sellers pay nothing.

In-depth M&A guide, DME businesses

Deep-dive guide on 2026 multiples (3x-12x EBITDA by subsegment), named public buyers (AdaptHealth, Lincare, Owens & Minor/Apria, ResMed) and PE-backed platforms (Numotion, National Seating). Sellers pay nothing.

In-depth M&A guide, addiction treatment centers

Deep-dive guide on 2026 multiples (3x-12x EBITDA), named public buyers (Acadia, UHS) and PE-backed platforms (BayMark, Pinnacle, Discovery, BHG). Includes EKRA, patient-brokering compliance, and the Kipu Health EMR playbook. Sellers pay nothing.

In-depth M&A guide, outpatient imaging centers

Deep-dive guide on 2026 multiples (4x-12x EBITDA), named public buyers (RadNet, Akumin) and PE-backed platforms (SimonMed, US Radiology Specialists). Sellers pay nothing.

In-depth M&A guide, MedSpas and aesthetic clinics

Deep-dive guide on 2026 multiples (2x-10x), named PE-backed platforms (Skytale, LaserAway, Ideal Image, Cortes NLD), corporate-practice-of-medicine compliance, and the injectables playbook. Sellers pay nothing.

In-depth M&A guide, dermatology practices

Deep-dive guide on 2026 multiples (5x-14x EBITDA), named PE-backed MSOs (Schweiger/GTCR, Forefront/Partners Group, Advanced Derm/Harvest, US Dermatology Partners/ABRY, Epiphany/Audax). Sellers pay nothing.

In-depth M&A guide, auto collision repair

Deep-dive guide on 2026 multiples (2.5x-9x), named MSOs (Caliber/H&F, Gerber/Boyd, Crash Champions/Clearlake, Driven Brands), DRP carrier strategy, and the OEM-cert playbook. Sellers pay nothing.

In-depth M&A guide, car wash businesses

Deep-dive guide on 2026 multiples (3x-12x EBITDA), named public/PE buyers (Mister Car Wash, Take 5/Driven, ZIPS, Tidal Wave, Quick Quack, El Car Wash), the express-tunnel playbook, and the post-peak market reset. Sellers pay nothing.

In-depth M&A guide, fleet maintenance businesses

Deep-dive guide on 2026 multiples (3x-9x EBITDA), named buyers (Dickinson Fleet/Cox, Mavis Tire, Monro, Bridgestone) and PE platforms (BayPine, Saban, Riverside, ABRY). Sellers pay nothing.

In-depth M&A guide, solar installation

Deep-dive guide on 2026 multiples (2x-7x EBITDA, post-reset), named buyers (Sunrun, Sunnova, Freedom Forever, Palmetto, ION, PosiGen), unit-economics audit. Sellers pay nothing.

In-depth M&A guide, water treatment

Deep-dive guide on 2026 multiples (3x-9x EBITDA), named buyers (Culligan/BDT, Pentair, EcoWater/Marmon, Kinetico, Watts, A.O. Smith). Sellers pay nothing.

In-depth M&A guide, commercial laundry

Deep-dive guide on 2026 multiples (4x-10x EBITDA), named buyers (Cintas, UniFirst, Vestis spinoff, Alsco, ImageFIRST, Crown Linen). Sellers pay nothing.

In-depth M&A guide, security guard businesses

Deep-dive guide on 2026 multiples (2.5x-8x), named buyers (Allied Universal/Warburg+CDPQ, GardaWorld/BC Partners, Securitas, Constellis/Triton). Sellers pay nothing.

In-depth M&A guide, engineering firms

Deep-dive guide on 2026 multiples (5x-13x EBITDA), named public buyers (Stantec, Tetra Tech, NV5, Bowman) and PE platforms (Ardurra, Verdantas/Sterling, IMEG, Salas O’Brien). IIJA/BIL tailwind. Sellers pay nothing.

In-depth M&A guide, architecture firms

Deep-dive guide on 2026 multiples (3x-9x EBITDA), named buyers (Stantec, Arcadis/CRTKL, HKS, Page) plus the thinner-buyer-pool reality and ESOP alternatives. Sellers pay nothing.

In-depth M&A guide, recycling businesses

Deep-dive guide on 2026 multiples (3x-9x EBITDA), named scrap-metal consolidators (Radius/RDUS, SA Recycling, EMR, OmniSource) and solid-waste giants (WM, Republic, GFL, Casella). Specialty EV/e-waste streams. Sellers pay nothing.

In-depth M&A guide, ophthalmology practices

Deep-dive guide on 2026 multiples (5x-14x EBITDA), named MSOs (EyeCare Partners/Partners Group, US Eye/Quad-C, US Ophthalmic Partners/Tenex, Retina Consultants of America/Webster, Spectrum Vision/CD&R). Sellers pay nothing.

In-depth M&A guide, optometry practices

Deep-dive guide on 2026 multiples (2.5x-10x), named OD-MSOs (MyEyeDr/GSAM, EyeCare Partners/Partners Group, Visionworks/Versant Health, AEG Vision/AEA). Sellers pay nothing.

In-depth M&A guide, hospice businesses

Deep-dive guide on 2026 multiples (4x-11x), named buyers (VITAS/Chemed, Addus, Compassus, BrightSpring, AccentCare/Advent), CMS HQRP + OIG compliance playbook. Sellers pay nothing.

In-depth M&A guide, non-medical home care

Deep-dive guide on 2026 multiples (3x-9x), named buyers (BAYADA, Honor/Bain+a16z, Senior Helpers/AAH, Comfort Keepers/Sodexo, Help at Home/Vistria+Centerbridge, Addus). Sellers pay nothing.

In-depth M&A guide, pain management practices

Deep-dive guide on 2026 multiples (4x-11x), named buyers (USAP/Welsh Carson+Berkshire+GIC, NAPA/Am. Securities, National Spine & Pain), ASC + opioid-compliance playbook. Sellers pay nothing.

In-depth M&A guide, medical staffing businesses

Deep-dive guide on 2026 multiples (2.5x-9x), named buyers (AMN, Cross Country, Aya, Maxim, Medical Solutions/TPG, Fusion/Aldrich). Sellers pay nothing.

In-depth M&A guide, plastic surgery practices

Deep-dive guide on 2026 multiples (2.5x-10x), named buyers (SkinSpirit/Leonard Green, Sono Bello/Aurora, Skytale, Cortes NLD, Plastic Surgery Partners). Sellers pay nothing.

In-depth M&A guide, specialty pharmacy

Deep-dive guide on 2026 multiples (4x-12x), payer-integrated giants (Cigna Accredo, CVS Specialty, Optum, Walgreens), and PE-backed (Soleo/Court Square, CSI/Linden, Avita). LDD access playbook.

In-depth M&A guide, dialysis businesses

Deep-dive guide on 2026 multiples (5x-11x), named buyers (DaVita NYSE: DVA, Fresenius NYSE: FMS own ~80%; US Renal Care/Bain+GS+LGP, Innovative Renal Care/Nautic, Satellite Healthcare, Strive Health). Sellers pay nothing.

In-depth M&A guide, fertility clinics

Deep-dive guide on 2026 multiples (5x-14x EBITDA), named buyers (Inception Fertility/Lee Equity+Morgan Stanley Cap, US Fertility/Lee Equity+Amulet, Pinnacle Fertility, Kindbody, IVI/RMA/KKR). Sellers pay nothing.

In-depth M&A guide, rigid packaging

Deep-dive guide on 2026 multiples (5x-11x), named buyers (Berry Global BERY, Sonoco SON, Silgan SLGN, Pactiv-Evergreen PTVE, Crown Holdings CCK, Greif GEF, Sealed Air SEE, O-I). Sellers pay nothing.

In-depth M&A guide, cold storage

Deep-dive guide on 2026 multiples (7x-14x EBITDA), named buyers (Lineage Logistics/Bay Grove+Stonepeak+GIC, Americold COLD, US Cold Storage/Swire, Burris, NewCold/Westport). Infrastructure-grade economics. Sellers pay nothing.

In-depth M&A guide, last-mile delivery

Deep-dive guide on 2026 multiples (2.5x-8x), named buyers (XPO, Saia, Forward Air, OnTrac/PE, GLS US, Veho, AxleHire, Better Trucks). Amazon DSP + 1099 classification + tech-enabled playbook.

In-depth M&A guide

Deep-dive guide on 2026 multiples (6x-11x), named buyers (Sysco SYY, US Foods USFD, PFG PFGC, Gordon Food Service, Cheney Brothers). Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (7x-13x, beer state-protected franchises premium), named buyers (Reyes Holdings, Southern Glazer’s, RNDC, Coca-Cola Consolidated COKE). Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (20x-30x EBITDA, highest in this entire series), named buyers (American Tower AMT, Crown Castle CCI, SBA Communications SBAC, Vertical Bridge), infrastructure-fund economics. Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (4x-10x EBITDA), named mechanical contractors (EMCOR EME, Comfort Systems FIX, Limbach LMB, Southland Industries). Distinct from residential HVAC PE roll-ups. Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (4x-9x EBITDA), named buyers (AmeriGas/UGI, Suburban Propane SPH, Ferrellgas, Sharp Energy/Chesapeake Utilities), customer-tank ownership moat. Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (4x-9x EBITDA), named buyers (World Kinect INT formerly World Fuel Services, Pilot Company/Berkshire, Mansfield Energy, Sun Coast Resources). Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (5x-11x EBITDA), named buyers (ProAmpac/Pritzker, Amcor AMCR, Berry Global BERY, Sonoco SON, Sealed Air SEE). Sustainability + recyclable mono-material focus. Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (5x-11x EBITDA), named buyers (Healogics/Bain+Berkshire, Restorix Health, Vohra Wound Physicians). Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (5x-13x EBITDA), named PE-backed MSOs (US Orthopaedic Partners/Welsh Carson, HOPCo, Spire Orthopedic Partners, Resurgens, OrthoLazer). Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (6x-13x EBITDA), named PE-backed MSOs (GI Alliance/Apollo, US Digestive Health/Amulet+Frazier, One GI/Frazier, Allied Digestive, Gastro Health/CVS Health). Endoscopy ASC focus. Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (6x-12x EBITDA), named PE-backed MSOs (US Heart & Vascular/Ares, Cardiovascular Associates of America/Webster Equity, US Cardiology Partners). Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (6x-12x EBITDA), named PE-backed MSOs (US Urology Partners/NMS, Solaris Health/Lee Equity, United Urology Group, Premier Urology Group). Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (6x-12x EBITDA), named PE-backed MSOs (Axia Women’s Health/Audax+Partners Group, Unified Women’s Healthcare/Altas+KKR, Women’s Health USA, MEDNAX/Pediatrix). Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (8x-13x EBITDAR), named REITs (Welltower WELL ~$35B+, Ventas VTR ~$20B+) + operators (Brookdale BKD, Atria, Sunrise, Discovery Senior Living). Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (3x-9x EBITDA), named DSOs (Heartland Dental/KKR+OTPP ~2,500+ offices, Aspen Dental/Leonard Green+Ares, Smile Brands/New Mountain Capital, MB2 Dental/Charlesbank, Pacific Dental Services). Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (10x-18x EBITDA, among the highest in healthcare-services), named buyers (Mars/VCA+BluePearl+Banfield, NVA/KKR+Berkshire, Thrive Pet Healthcare/TSG, MedVet, VEG). Cash-pay model + aging-pet demand. Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (3x-12x EBITDA, varies wildly), named buyers (ChargePoint CHPT, Blink BLNK, EVgo EVGO, Tesla, BP Pulse, Shell Recharge, Pilot/Berkshire). NACS + NEVI + post-SPAC rationalization. Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (5x-11x EBITDA), named buyers (BluSky/Partners+Kohlberg, BELFOR/American Securities+GS, Servpro/Blackstone, ATI Restoration, First Onsite/FSV, PuroClean, Rainbow Restoration). TPA + insurance carrier programs. Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (3x-7x EBITDA), named buyers (Halliburton HAL, SLB, Baker Hughes BKR, ChampionX CHX, Liberty Energy LBRT, ProPetro PUMP). Permian premium, E-frac, EPA OOOOb/c methane rules. Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (3x-7x EBITDA), named buyers (College Hunks/Authority Brands/Apax+GS, 1-800-Got-Junk/O2E Brands, JDog, Junkluggers, LoadUp). Commercial account revenue + dumpster integration. Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (4x-9x EBITDA), named buyers (NorthStar/Sun Capital, MasTec MTZ, Veit, Brandenburg, AECOM ACM, Sterling Infrastructure STRL). Industrial / environmental remediation premium. Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (5x-10x EBITDA), named buyers (Maxim Crane/Apollo post-TNT 2024, ALL Family, Bigge, Barnhart, Brandsafway/Brookfield, United Rentals URI, Sunbelt AHT). Large-tonnage + industrial MSAs drive multiple. Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (8x-14x EBITDA), named buyers (Sonepar ~$32B+, Rexel RXL, WESCO WCC, Graybar Electric, CED ~700+ branches, Border States). Industrial/utility/data center mix + supplier authorization breadth. Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (3x-7x EBITDA), named buyers (Empire Today/Charlesbank, Long Fence, Glidewell, AFC American Fence, Hercules Fence, Master Halco/Brookfield). Commercial/industrial/security mix + recurring service. Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (5x-9x EBITDA), named buyers (Service Corp Int’l SCI ~16% US share, Carriage Services CSV, Park Lawn PLC, StoneMor/Axar, Foundation Partners/Access Holdings Tulip/Solace). Preneed backlog + cremation + cemetery integration. Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (5x-10x EBITDA), named buyers (Brandsafway/Brookfield ~$4B+ revenue, Sunbelt Rentals AHT, United Rentals URI, Layher, PERI, Apache Industrial). Refinery/power/petrochemical/data center industrial mix + EHS posture. Sellers pay nothing.

In-depth M&A guide

Deep-dive guide on 2026 multiples (5x-10x EBITDA), named buyers (EMCOR EME ~$14B+, Comfort Systems FIX, API Group APG, MasTec MTZ, Limbach LMB, Apache Industrial). ASME B31.1/B31.3/AWS/NCPWB + high-purity / pharmaceutical / semiconductor (CHIPS Act). Sellers pay nothing.

In-depth buy-side guide

The ROI case for retained buy-side M&A advisor: 3-7x return on advisor cost via compressed timeline, proprietary deal access, negotiation protection. When to hire vs. build internal corp dev.

In-depth buy-side guide

Buy-side mandate structure: retainer + success fee, 90-day milestones, sector exclusivity, tail period. What to negotiate before signing. CT Strategic Partners structures with lighter retainer + larger success fee.

In-depth buy-side guide

5-step vetting playbook: thesis, candidate identification, references (3-5 prior buyer clients), engagement negotiation, commitment. The biggest signal of strong advisor: introduces 3+ references within 2 weeks.

In-depth buy-side guide

Retainer ranges by deal size, Lehman / Double Lehman / modified Lehman / flat-rate success fees compared. $10M deal: Lehman $190k vs. Double Lehman $380k vs. flat-rate 1.5% $150k. Negotiate before signing.

In-depth buy-side guide

What is a PE firm: fund structure, top US firms (Blackstone $1.1T, Apollo $700B, KKR $580B, Brookfield, Ares, Carlyle), platform vs. add-on, LBO mechanics, 2026 multiples by sector. CT runs retained mandates for PE platforms doing add-ons.

In-depth buy-side guide

Complete 7-phase M&A process: thesis (wks 1-4), sourcing (wks 4-16), LOI (wks 16-20), QoE (wks 20-24), full diligence (wks 22-26), Purchase Agreement (wks 26-30), closing + 100-day plan. Compressed 6-12 months with retained advisor.

In-depth buy-side guide

Business acquisition definition + legal structures (APA / SPA / MIPA), transaction types (LBO / strategic / MBO / search fund / FO / IS), key terms (LOI / QoE / earn-out / rollover / R&W insurance). What every buyer should know.

In-depth buy-side guide

Complete M&A glossary: legal structures (APA / SPA / MIPA), process documents (LOI / QoE / Purchase Agreement), financial metrics (EBITDA / SDE / multiple / WC target), risk allocation (indemnification / escrow / earn-out / rollover / R&W insurance).

In-depth buy-side guide

Acquisition strategy framework: thesis discipline, capital structure, deal velocity targets, integration playbook, exit planning. Strategy by buyer type (PE 1+5/5yrs, strategic 0.3-1/yr, FO 0.5-1.5/yr, SF 1 total, IS 0.5-1.5/yr).

In-depth buy-side guide

Complete roll-up playbook: multiple arbitrage (3-5x add-on entry vs. 9-14x exit), top US roll-up sectors (healthcare, home services, auto, funeral, industrial dist), named PE platforms (Caliber, Heartland, Mars Petcare, SCI, Neighborly, Authority Brands, Apex HVAC).

In-depth buy-side guide

Top US roll-up case studies: Heartland Dental (KKR+OTPP ~2,500), Caliber Collision (H&F+OMERS ~1,800), Mars Petcare Vet (~2,100), SCI (~1,500 funerals + 470 cemeteries), Apex HVAC (~60 add-ons in 2025), Blackstone-Champions ($2.5B at 18.5x Feb 2026).

In-depth buy-side guide

Top US PE roll-up sponsors by sector: Healthcare (KKR, Bain, Welsh Carson, Ares, Webster, Audax, Apax+GSAM, Frazier, Tenex, Linden); home services (Roark, Apax+GSAM, Alpine+Brightstar, Charlesbank); auto (H&F+OMERS, Clearlake); industrial dist (CD&R, Advent, Apollo); funeral (Access, Axar).

In-depth buy-side guide

Roll-up financing: platform capital structure (50-65% senior + mezz + 35-50% PE equity + 10-30% seller rollover) plus add-on funding (DDTL, incremental term loans, sponsor follow-on, per-deal seller financing). Top US sponsor debt: Apollo, Ares, Antares, Golub, MidCap.

In-depth buy-side guide

Acquisition financing: 6 primary capital sources (SBA 7(a), senior debt, mezz, buyer equity, seller financing, earn-out, rollover). Structure by deal size: sub-$5M SBA-driven; $5-25M senior+mezz+equity+seller; $25M+ adds PE rollover. Top lenders: Live Oak (LOB), Apollo, Ares (ARCC), Antares (CPPIB), Golub (GBDC), MidCap (KKR).

In-depth buy-side guide

100% acquisition financing: SBA 7(a) + ROBS rollover + seller financing combinations that zero out buyer cash. USDA B&I for rural deals. Top SBA lenders: Live Oak (LOB largest), Newtek (NEWT), Huntington, Byline, Pursuit. ROBS providers: Benetrends, Guidant, Tenet.

In-depth buy-side guide

No-money-down structures: SBA 7(a) + ROBS rollover + seller financing (zero buyer cash at closing), search fund LP-funded acquisitions, HELOC alternatives. Buyer profile fit required: prior operator with sector experience + 720+ FICO. Personal guarantee + retirement fund risk.

In-depth buy-side guide

LBO capital structure: 35-45% senior + 10-15% mezz + 30-40% sponsor equity + 10-15% seller financing + 0-15% earn-out. Total leverage 4-6x EBITDA (down from 6-7x in 2021). Top sponsor debt: Apollo, Ares (ARCC), Antares (CPPIB), Golub (GBDC), MidCap (KKR), Madison, Twin Brook, Owl Rock (OBDC), Monroe (MRCC), Crescent (CCAP).

Vendor comparison guide

Top 10 VDRs compared: Intralinks (SS&C), Datasite, Firmex, iDeals, Ansarada, FirmRoom, DealRoom, Onehub, Caplinked, Box. Pricing $1-150k/year. Match VDR to deal size + counterparty expectations.

Vendor comparison guide

Top 7 M&A CRMs: DealCloud (Intapp, $50-200k+), Affinity ($15-60k), Intapp Suite ($75-250k+), 4Degrees ($5-25k LMM), Navatar (Salesforce-native), Salesforce FSC, HubSpot. Match CRM tier to firm AUM + deal volume.

Vendor comparison guide

Top 6 DD platforms: DiliTrust (VDR+GRC), Drooms (European), Donnelley Financial (NYSE: DFIN, public-company M&A), DealRoom (workflow hybrid), Datasite (AI tagging), Onehub (budget). Match platform to deal type.

Vendor comparison guide

Top 10 CLM platforms for M&A LOIs + Purchase Agreements: Ironclad ($30-200k+ enterprise, AI Assist), DocuSign CLM, PandaDoc ($19-89/user/mo SMB), Concord, Agiloft, ContractWorks (flat-rate), LinkSquares, Evisort, Juro (European), Spotdraft (AI cost-effective). AI-first or workflow-first architectural choice.

Vendor comparison guide

Top 7 valuation platforms: BizEquity (SMB, ~250k+ valuations/yr), ValuSource (credentialed appraisers ABV/CVA/ASA, industry standard 40+ years), PeerComps (SMB comp database 50k+ deals), Equidam (startup/tech), Eqvista (cap-table + 409a), Carta ($7B valuation, industry-standard cap-table + 409a), Aranca (outsourced services).

Vendor comparison guide

Top 7 PE research platforms: PitchBook + Capital IQ + FactSet (NYSE: FDS) + Sourcescrub + Grata + CB Insights + Preqin (BlackRock 2024). Per-user $10-100k+/yr.

Vendor comparison guide

Top 7 firms: Heidrick (HSII), Korn Ferry (KFY), Russell Reynolds, Spencer Stuart (‘big four’, $200k-1M+ retainer); JM Search, ZRG, Lochlin ($80-250k mid-market).

Vendor comparison guide

Top 7: Mariner (Lovell Minnick + Leonard Green, ~$100B AUM), Mercer (Genstar + Oak Hill ~$60B), CAPTRUST (Carlyle + GTCR ~$700B), Wealth Enhancement (TA + Onex ~$80B), Beacon Pointe, Creative Planning (~$300B), Fisher (~$200B). 0.5-1.25% AUM.

Vendor comparison guide

Top 6: Paro (largest marketplace, ~$100M+ ARR), Driven Insights, Preferred CFO (tech/SaaS), vCFO (SMB boutique), CFO Hub (transition), B2B CFO. $3-30k/month.

Vendor comparison guide

Top 6 cyber DD firms: Mandiant (Google Cloud, $5.4B 2022 acquisition), CrowdStrike Services (NASDAQ: CRWD), NCC Group (UK independent), Bishop Fox (tech/SaaS specialist), BlueVoyant (supply chain), Optiv (largest US cyber svc).

Vendor comparison guide

Top 6 R&W brokers: Marsh (NYSE: MMC, ~$23B), Aon (NYSE: AON, ~$13B), Lockton (largest private), Willis Towers Watson (NASDAQ: WTW, ~$10B); Crum & Forster (Fairfax direct underwriter); Hub International (Hellman & Friedman, LMM).

Vendor comparison guide

Top 6 SBA 7(a) lenders: Live Oak Bank (NASDAQ: LOB, largest by volume ~$10B portfolio), Newtek (NASDAQ: NEWT), Huntington National Bank (NASDAQ: HBAN, largest by # of loans), Byline, Pursuit (CDFI), US Bank (NYSE: USB). Up to $5M, 90% guaranteed.

Vendor comparison guide

Top 6: Carta (industry standard, ~$300M ARR, $7B valuation), Aranca, Eqvista (budget), Pulley (modern Carta alt), Stout, Kroll (Duff & Phelps). Required every 12 months + at material events.

Vendor comparison guide

Top 7: FTI Consulting (NYSE: FCN, ~$3.5B, largest), Kroll (Duff & Phelps, ~$2B), AlixPartners (turnaround), BDO Forensic + RSM Forensic (mid-market), Charles River Associates (NASDAQ: CRAI, antitrust), Berkeley Research Group.

Vendor comparison guide

Top 7 home services marketing agencies: Hook Agency (roofing), Scorpion (BV Investment, ~$200M revenue multi-vertical platform), Blue Corona (EverCommerce NASDAQ: EVCM, HVAC+plumbing), Service Direct (pay-per-lead), ServiceTitan Marketing Pro (NYSE: TTAN), RYNO, Optix.

Vendor comparison guide

Top 8 outreach tools: Apollo.io (~$1.6B valuation comprehensive), ZoomInfo (NASDAQ: ZI, $1.2B+ revenue enterprise), Clay (AI-powered), Lemlist (email personalization), Instantly.ai (cold email at scale), Outreach.io (enterprise), Salesloft (revenue orchestration), LinkedIn Sales Navigator.